An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A. Soucy, Steven Langston, Peter G. Smith et al.|Nature|2009Cited by 2k
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In SituJames E. Brownell, Lawrence R. Dick, Michael D. Sintchak et al.|Molecular Cell|2010Cited by 461
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphomaMichael A. Milhollen, Peter G. Smith, Tary Traore et al.|Blood|2010Cited by 323
Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic MalignanciesAline Renneville, Benjamin L. Ebert, Kaushik Viswanathan et al.|Blood Cancer Discovery|2021Cited by 46